Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash Flow for Capital Expenditures
$-757 Mil (TTM As of Dec. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novo Nordisk A/S's cash flow for capital expenditures for the three months ended in Dec. 2014 was $-259 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2014 was $-757 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novo Nordisk A/S Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Dec. 2014 was -148.38829196 (Mar. 2014 ) + -162.045897814 (Jun. 2014 ) + -187.336599893 (Sep. 2014 ) + -258.984938112 (Dec. 2014 ) = $-757 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Cash Flow_CPEX -620-588-474-370-600-690-590-637-670-718

Novo Nordisk A/S Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
Cash Flow_CPEX -179-201-156-158-180-157-148-162-187-259
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK